Breast cancer systemic treatment

Breast cancer systemic treatment

Julie Scott, DNP
Julie Scott, DNP

The exact treatment prescribed for you will be based on the stage and characteristics of your breast cancer. It’s important to talk to your oncology team if you have any specific questions about your particular treatment. 

Treatment is often classified into local therapy or systemic therapy. Local therapy means that it only treats the breast, and not any other parts of the body. Systemic therapy is treatment that goes around your entire body, treating cancer cells that may be present outside of the breast. A combination of local and systemic therapy may be given for breast cancer. 

This article will focus on the systemic therapy options for breast cancer – chemotherapy, hormone therapy, and HER2 therapy. 

Chemotherapy

Chemotherapy is medication that is used to stop the division of cells, causing cell death. Because cancer cells are abnormal and usually grow out of control, they are killed by chemotherapy. Unfortunately, chemotherapy can cause side effects because healthy cells are affected as well. 

Chemotherapy can be given before surgery (called neoadjuvant chemo) or after surgery (adjuvant chemo). 

Some examples of chemotherapy used to treat breast cancer include:

  • Anthracyclines (Adriamycin)
  • Taxanes (Taxol, Taxotere)
  • Carboplatin
  • Cyclophosphamide

The specific side effects of chemotherapy can differ for each medication, as well as the dose that is given. 

Hormone Therapy

When breast cancer is ER+ and/or PR+, hormonal, or endocrine, therapy is given to prevent the growth of breast cancer cells. Some of these medications work by blocking the hormone receptors, while others work at decreasing levels of estrogen in the body. These medications are usually given for years to reduce the risk of breast cancer coming back. Some examples of hormone therapy include:

  • Tamoxifen
  • Aromatase inhibitors (Femara, Arimidex, Aromasin)
  • Faslodex
  • Zoladex
  • Lupron

Side effects can differ for each medication, but are generally related to low levels of estrogen (ex: hot flashes, vaginal dryness, decreased bone density).

HER2 Therapy

If breast cancer is HER2+, systemic therapy to target the HER2 receptors specifically is given to treat the breast cancer. These are usually used in combination with chemotherapy, and multiple HER2 medications may be used together. Some examples of HER2 targeted therapy used for early stage breast cancer include Herceptin and Perjeta. 

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
Mental Health Support During Cancer Care
March 13, 2023

Cancer is a devastating illness that affects not only the physical health of an individual but also their mental health. The diagnosis of cancer can be overwhelming, causing feelings of fear, anxiety, and depression. The treatment process can also be grueling, causing additional stress, exhaustion, and feelings of hopelessness. While…

Jenni Daniel BSN, RN

author

Articles
Amyloidosis
March 1, 2023

What is Amyloidosis? Amyloidosis is a rare condition that occurs when an abnormal protein, called amyloid, builds up in the body's organs and tissues. Over time, this buildup can cause damage and lead to organ failure. Here's an overview of the symptoms, diagnosis, and treatment of amyloidosis. Symptoms The symptoms…

Julie Scott, DNP

author

Articles
What is mantle cell lymphoma?
December 22, 2022

Mantle cell lymphoma is a type of non-Hodgkin's lymphoma cancer that grows in the lymphatic system. The lymphatic system is responsible for moving fluids around the body and transporting the immune system. Mantle cell lymphoma is not common and is responsible for less than 10% of lymphoma diagnoses. It’s most…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice